View Author
patient myeloma lenalidomide dexamethasone therapy study response survival treatment blood serum university trial thalidomide group bortezomib combination cancer factor table hospital chain month phase regimen light high-dose disease meeting abstracts signi department stage signi ficantly level hematology grade cell transplantation result leukemia high-dose therapy progression recommendation transplantation urine marrow high-dose dexamethasone institute criteria diagnosis g-csf reduction palumbo number 50 years assay group guidelines ef ficacy chemotherapy center randomized plasma meeting abstract cell collection celgene prognostic agent 100 ml guideline cyclophosphamide mobilization outcome collection mayo clinic clinic analysis melphalan effect serum flc assay figure
7 Most Recent Publications
|
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
(Article)
Kumar, S. Lee, J.H. Leleu, X. Hulin, C. Klein, S.K. Sonneveld, P. Siegel, D. Bladé, J. Goldschmidt, H. Jagannath, S. Miguel, J.S. Orlowski, R.Z. Lahuerta, J.J. Palumbo, A. Sezer, O. Rajkumar, S.V. Durie, B.G.M. Morgan, G. Richardson, P.G. Crowley, J. Haessler, J. Feather, J. Hoering, A. Moreau, P. |
2012-01-01
|
|
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
(Article)
Kumar, S. Giralt, S. Miguel, J.S. Ludwig, H. Bergsagel, L. Bladé, J. Lonial, S. Anderson, K.C. Tosi, P. Sonneveld, P. Sezer, O. Vesole, D. Stadtmauer, E.A. Cavo, M. Einsele, H. Richardson, P.G. Durie, B.G.M. Rajkumar, S.V. Harousseau, J-L. Palumbo, A. Bensinger, W. Comenzo, R.L. Lentzsch, S. Munshi, N.C. Niesvizky, R. |
2009-11-20
|
|
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
(Article)
Palumbo, A. Sezer, O. Kumar, S. Hajek, R. Giralt, S. Bringhen, S. Anderson, K.C. Richardson, P.G. Cavo, M. Davies, F. Bladé, J. Einsele, H. Kyle, R. Dimopoulos, M.A. Spencer, A. Dispenzieri, A. Reiman, T. Shimizu, K. Lee, J.H. Attal, M. Boccadoro, M. Mateos, M.V. Chen, W. Miguel, J.S. Ludwig, H. Joshua, D. Chim, J. Hungria, V. Turesson, I. Durie, B.G.M. Lonial, S. Orlowski, R.Z. Moreau, P. Niesvizky, R. Morgan, G. Comenzo, R.L. Sonneveld, P. |
2009-06-08
|
|
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
(Article)
Palumbo, A. Dimopoulos, M.A. Miguel, J.S. Harousseau, J-L. Attal, M. Hussein, M. Knop, S. Ludwig, H. Lilienfeld-Toal, M. Von Sonneveld, P. |
2009-03-01
|
|
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
(Article)
Dispenzieri, A. Kyle, R. Dimopoulos, M.A. Comenzo, R.L. Einsele, H. Barlogie, B. Anderson, K.C. Gertz, M. Harousseau, J-L. Attal, M. Tosi, P. Sonneveld, P. Merlini, G. Boccadoro, M. Morgan, G. Richardson, P.G. Sezer, O. Mateos, M.V. Cavo, M. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Miguel, J.S. Powles, R. Rajkumar, S.V. Durie, B.G.M. Ludwig, H. Hajek, R. Palumbo, A. Jagannath, S. Bladé, J. Lonial, S. |
2009-01-01
|
|
Lenalidomide: A new therapy for multiple myeloma
(Article)
Palumbo, A. Miguel, J.S. Sonneveld, P. Moreau, P. Drach, J. Morgan, G. Einsele, H. |
2008-05-01
|
|
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: An analysis of 10 549 patients from the International Myeloma Working Group
(Article)
Ludwig, H. Durie, B.G.M. Westin, J. Harousseau, J-L. Beksac, M. Boccadoro, M. Palumbo, A. Barlogie, B. Shustik, C. Cavo, M. Greipp, P. Joshua, D. Bolejack, V. Attal, M. Sonneveld, P. Crowley, J. Turesson, I. Kyle, R. Bladé, J. Fonseca, R. Dimopoulos, M.A. Shimizu, K. Miguel, J.S. |
2008-04-15
|
